ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,789,000 | -19.9% | 258,214 | -15.4% | 0.24% | -19.7% |
Q2 2022 | $3,480,000 | -23.8% | 305,253 | -39.1% | 0.30% | -17.6% |
Q1 2022 | $4,566,000 | -69.3% | 501,219 | -49.7% | 0.36% | -62.3% |
Q4 2021 | $14,862,000 | -36.8% | 996,116 | +8.9% | 0.95% | -35.0% |
Q3 2021 | $23,500,000 | +16.5% | 914,416 | +18.2% | 1.46% | +42.6% |
Q2 2021 | $20,174,000 | +6.5% | 773,562 | +44.1% | 1.02% | -18.6% |
Q1 2021 | $18,947,000 | – | 536,738 | – | 1.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |